Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Drug Deliv Transl Res. 2016 Feb;6(1):1–16. doi: 10.1007/s13346-015-0269-4

Figure 1. Cleavage kinetics of HIV-1 PR FRET peptide substrate (5.0µM) by recombinant HIV-1 PR (35.2 nM) at 37 °C in the assay buffer in the presence of different APV concentrations (0–5.0 µM).

Figure 1

All measurements were performed in triplicate and reported as mean ± SD (n = 3). The effect of APV 3.5 µM and 5.0 µM was not significantly different (p>0.05).